Bullish Signal: Khemani Sees Buying Opportunity in Banking, Aviation, Pharma

Vikas Khemani of Carnelian Asset Management has identified the current Indian market correction as a strategic buying opportunity for long-term investors. He specifically highlights the banking, aviation, and pharmaceutical sectors as having significant potential for growth over the next two to three years, driven by an anticipated easing of geopolitical tensions.

This perspective from a prominent asset manager suggests a contrarian view, advocating for investment during a market downturn. It's significant for Indian traders as it points towards specific sectors that could outperform in the medium term, offering a potential roadmap for capital allocation if his thesis on geopolitical stability and market rebound holds true.

The banking sector, including major players like HDFCBANK, ICICIBANK, and SBIN, could see renewed investor interest. Aviation stocks such as INDIGO and SPICEJET are likely to benefit from improved travel sentiment and reduced geopolitical risks. Pharmaceutical companies like DRL, SUNPHARMA, and CIPLA are also poised for positive impact, potentially attracting fresh capital flows.

Traders should monitor global geopolitical developments for signs of de-escalation, as this is a key driver for Khemani's thesis. Additionally, keep an eye on quarterly earnings reports from these sectors for confirmation of improving fundamentals and any shifts in FII/DII investment patterns, which could signal broader market sentiment changes.

• •Indian markets are down, presenting a buying opportunity for long-term investors.
• •Vikas Khemani of Carnelian Asset Management sees potential in banking, aviation, and pharma sectors.
• •He believes geopolitical fears are fading, which could lead to a market bounce.
• •Investors with a two to three year outlook can find good prices on desired stocks.